Insider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 1,586 Shares …

Q: Is Evolus a profitable stock?

Full-year revenue guidance was “narrowed” to $260m - $266m — an annual uplift of 29% - 32% — and stated it would be profitable on a non-GAAP basis in Q4 2024, and in full-year 2025, and finally, that it: Despite the generally positive nature of these updates, Evolus stock slipped <$12 per share by the middle of November.

Q: How many people have searched for Evolus on marketbeat?

Only 3 people have searched for EOLS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. In the past three months, Evolus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $41,642.00 in company stock.

Q: How much did Evolus IPO cost?

Evolus (EOLS) raised $65 million in an IPO on Thursday, February 8th 2018. The company issued 5,000,000 shares at a price of $12.00-$14.00 per share. Cantor and Mizuho Securities served as the underwriters for the IPO and SunTrust Robinson Humphrey and JMP Securities were co-managers. How do I buy shares of Evolus?

Q: Should you buy Evolus stock after Q3 earnings?

Unfortunately, although Evolus stock enjoyed a strong bull run between June and early November last year, with shares reaching a high of $17 per share, a market cap valuation of roughly just under $1bn, it then began to tumble in value after Evolus released a weak set of Q3 earnings. At first, the results and updates appear quite positive.

Q: What was Evolus' stock price in 2025?

Evolus' stock was trading at $11.04 at the beginning of 2025. Since then, EOLS stock has decreased by 7.5% and is now trading at $10.21. How were Evolus' earnings last quarter? Evolus, Inc. (NASDAQ:EOLS) released its quarterly earnings results on Tuesday, March, 23rd.

Dec 27, 2024 · Evolus, Inc. (NASDAQ:EOLS - Get Free Report) CFO Sandra Beaver sold 1,586 shares of the stock in a transaction on Monday, December 23rd. The shares were sold at an …

$17208.10
OFF

Evolus, Inc. (NASDAQ:EOLS) CFO Sells $17,208.10 In Stock

1 week from now

Dec 27, 2024 · Evolus, Inc. (NASDAQ:EOLS - Get Free Report) CFO Sandra Beaver sold 1,586 shares of the firm's stock in a transaction dated Monday, December 23rd. The shares were …

marketbeat.com

34%
OFF

Evolus CFO Sandra Beaver Sells Shares Worth $17,211 - Investing.com

1 week from now

Dec 26, 2024 · Sandra Beaver, Chief Financial Officer of Evolus, Inc. (NASDAQ: EOLS), a company that has shown strong revenue growth of 34% in the last twelve months, recently …

investing.com

34%
OFF

Evolus CFO Sandra Beaver Sells Shares Worth $17,211

1 week from now

Dec 26, 2024 · Sandra Beaver, Chief Financial Officer of Evolus, Inc. (NASDAQ: EOLS), a company that has shown strong revenue growth of 34% in the last twelve months, recently …

investing.com

34%
OFF

Evolus CFO Sandra Beaver Sells Shares Worth $17,211

1 week from now

Sandra Beaver, Chief Financial Officer of Evolus, Inc. (NASDAQ: EOLS), a company that has shown strong revenue growth of 34% in the last twelve months, recently sold 1,586 shares of …

investing.com

53%
OFF

Evolus (EOLS) Stock Price, News & Analysis - MarketBeat

1 week from now

3 days ago · 8.53% of the outstanding shares of Evolus have been sold short. Short Interest Ratio / Days to Cover ... Evolus insiders have sold more of their company's stock than they have …

marketbeat.com

$10.85
OFF

Evolus Executives Sell Shares To Cover Tax Obligations

1 week from now

Dec 26, 2024 · Sandra Beaver, Evolus' Chief Financial Officer, sold 1,586 shares at the same price of $10.8519, with a total sale amount of $17,211. After the sale, Beaver directly owns …

tradingview.com

$16771881.85
OFF

EOLS Insider Trading | Evolus Buys And Sells

1 week from now

Insider Selling (Last 12 Months): $16,771,881.85 Evolus Insider Trading History Chart This chart shows the insider buying and selling history at Evolus by year and by quarter.

insidertrades.com

34%
OFF

Evolus CFO Sandra Beaver Sells Shares Worth $17,211

1 week from now

Sandra Beaver, Chief Financial Officer of Evolus, Inc. (NASDAQ: EOLS), a company that has shown strong revenue growth of 34% in the last twelve months, recently sold 1,586 shares of …

investing.com

$55333
OFF

Regulus Therapeutics CFO Sells Shares Worth $55,333

1 week from now

2 days ago · On January 13, Calsada sold 38,716 shares at a price of $1.2632 per share, amounting to $48,906. This was followed by the sale of an additional 5,088 shares on January …

investing.com

FAQs about Insider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 1,586 Shares … Coupon?

What happened to Evolus stock in November?

Despite the generally positive nature of these updates, Evolus stock slipped <$12 per share by the middle of November. It mounted a slight comeback to ~$14 per share, then crashed again in December, and has kept falling to its current price of $9.3 per share. What, then, is turning the market against Evolus and its business? ...

Is Evolus a profitable stock?

Full-year revenue guidance was “narrowed” to $260m - $266m — an annual uplift of 29% - 32% — and stated it would be profitable on a non-GAAP basis in Q4 2024, and in full-year 2025, and finally, that it: Despite the generally positive nature of these updates, Evolus stock slipped <$12 per share by the middle of November. ...

How many people have searched for Evolus on marketbeat?

Only 3 people have searched for EOLS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. In the past three months, Evolus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $41,642.00 in company stock. ...

How much did Evolus IPO cost?

Evolus (EOLS) raised $65 million in an IPO on Thursday, February 8th 2018. The company issued 5,000,000 shares at a price of $12.00-$14.00 per share. Cantor and Mizuho Securities served as the underwriters for the IPO and SunTrust Robinson Humphrey and JMP Securities were co-managers. How do I buy shares of Evolus? ...

Should you buy Evolus stock after Q3 earnings?

Unfortunately, although Evolus stock enjoyed a strong bull run between June and early November last year, with shares reaching a high of $17 per share, a market cap valuation of roughly just under $1bn, it then began to tumble in value after Evolus released a weak set of Q3 earnings. At first, the results and updates appear quite positive. ...

What was Evolus' stock price in 2025?

Evolus' stock was trading at $11.04 at the beginning of 2025. Since then, EOLS stock has decreased by 7.5% and is now trading at $10.21. How were Evolus' earnings last quarter? Evolus, Inc. (NASDAQ:EOLS) released its quarterly earnings results on Tuesday, March, 23rd. ...